Daniela K van Santen

Biography

Publications

• Risk of Hepatocellular Carcinoma After Direct-Acting Antiviral Treatment for Hepatitis C Virus Infection in People With HIV.

  van Santen DK, Chalouni M, Berenguer J, Jarrin I, Miró JM, Klein MB, Young J, Torgersen J, Rentsch CT, Gill MJ, Epstein RL, Nunes D, Surial B, Rauch A, Touloumi G, Papadopoulos A, Wittkop L, Gilbert C, Leleux O, van der Valk M, Boyd A, Monforte AD, Puoti M, Zangerle R, Gisinger M, Logan RW, Rein S, Hernán MA, Lodi S. Clin Infect Dis 2026 May 20

  PMID: 41253696

• Risk of type 2 diabetes mellitus after treatment with direct-acting antivirals for hepatitis C virus in people with HIV.

  Chalouni M, Torgersen J, Rentsch CT, Van Santen DK, Jarrin I, Klein MB, Young J, Gill MJ, Epstein RL, Linas B, Zangerle R, Surial B, Nemeth J, Touloumi G, Papadopoulos A, Wittkop L, Van Der Valk M, Boyd A, Monforte AD, Puoti M, Logan RW, Rein SM, Miro JM, Berenguer J, Hernán MA, Lodi S. AIDS 2026 Aug 01

  PMID: 41879095

• Behavioural trajectories following DAA treatment for HCV among people with HIV: findings from an international consortium of prospective cohort studies.

  Hage K, Carson J, Hosseini-Hooshyar S, Sacks-Davis R, Stewart AC, Van Santen DK, Smit C, Van Der Valk M, Wittkop L, Klein MB, Doyle JS, Rauch A, Matthews GV, Hellard ME, Boyd A, Prins M. AIDS 2026 Apr 01

  PMID: 41263230

• Longitudinal trajectories of sexual behavior and incident hepatitis C reinfection among men who have sex with men with HIV.

  Hage K, Hamusonde K, van Santen DK, Newsum AM, van der Valk M, Brinkman K, Arends JE, Lauw FN, Rijnders BJA, van Eeden A, Salazar-Viscaya L, Schinkel J, Boyd A, Prins M. PLoS One 2026

  PMID: 40549687

• Liver Fibrosis Regression in People Living With HIV After Successful Treatment for Hepatitis C.

  Young J, Wang S, Sacks-Davis R, Stewart A, van Santen DK, van der Valk M, Doyle JS, Matthews G, Berenguer J, Wittkop L, Lacombe K, Rauch A, Stoové M, Hellard M, Klein MB. J Acquir Immune Defic Syndr 2025 Jun 01

  PMID: 39972551